| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.012 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0051 | 1 |